Company / Current Assets
BioAge Labs, Inc. Current Assets History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$286.8M
FY2025
5-year range
$25.3M / $357.1M
FY2023-FY2025
Trend
-19.7%
vs FY2024
Sector context
#169 of 213
Health Care
What the data says
BioAge Labs, Inc.'s current assets of $287M is lower than 79% of companies in the Health Care sector (FY2025). Improved from $25M to $287M over the past 2 years.
Based on SEC 10-K filings.
$287M in FY2025.
Improved from $25M to $287M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 21% in Health CareTop 79% of 213This company $286.8M Sector average $2.5B
▼
-88.6% below sector average
Key checks
Key Insights
- In FY2025, current assets decreased 19.7% year-over-year.
- Ranks #169 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.75 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $286.8M | -19.7% |
| FY2024 | $357.1M | +1311.1% |
| FY2023 | $25.3M | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026